The estimated Net Worth of Glen Y Sato is at least $42.3 millió dollars as of 24 May 2005. Glen Sato owns over 10,000 units of PDL Biopharma Inc stock worth over $42,327,228 and over the last 22 years Glen sold PDLI stock worth over $0.
Glen has made over 1 trades of the PDL Biopharma Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Glen exercised 10,000 units of PDLI stock worth $78,300 on 24 May 2005.
The largest trade Glen's ever made was exercising 10,000 units of PDL Biopharma Inc stock on 24 May 2005 worth over $78,300. On average, Glen trades about 3,333 units every 0 days since 2003. As of 24 May 2005 Glen still owns at least 11,738 units of PDL Biopharma Inc stock.
You can see the complete history of Glen Sato stock trades at the bottom of the page.
Glen's mailing address filed with the SEC is C/O PROTEIN DESIGN LABS, INC., 34801 CAMPUS DRIVE, FREMONT, CA, 94555.
Over the last 22 years, insiders at PDL Biopharma Inc have traded over $45,966,964 worth of PDL Biopharma Inc stock and bought 12,693,393 units worth $32,804,545 . The most active insiders traders include Point Capital L.P.O'shea Ro..., Faheem Hasnain és Laurence Jay Korn. On average, PDL Biopharma Inc executives and independent directors trade stock every 24 days with the average trade being worth of $245,074,578. The most recent stock trade was executed by Point Capital L.P.O'shea Ro... on 1 February 2021, trading 187,061 units of PDLI stock currently worth $383,475.
PDL Biopharma Inc executives and other stock owners filed with the SEC include: